CVS Health (CVS) vs Progyny (PGNY)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
Progyny (PGNY) has outperformed CVS Health (CVS) over the past year, gaining 37.8% versus a gain of 16.2%. Over five years, CVS leads with a +4.4% price change compared with -50.8% for PGNY. CVS Health is the larger company by market cap ($112.49 billion vs $2.11 billion), about 53.2 times the size.
On valuation, CVS Health trades at a lower forward P/E (10.3x vs 11.9x for Progyny). CVS Health pays a dividend yielding 3.02%, while Progyny does not currently pay one.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CVS | PGNY |
|---|---|---|
| Share price | $87.95 | $27.55 |
| Market cap | $112.49B | $2.11B |
| 1-day change | +1.76% | +6.33% |
| YTD return | +12.88% | +7.28% |
| 1-year return | +16.16% | +37.75% |
| 5-year return | +4.36% | -50.79% |
| P/E ratio (TTM) | 23.14 | 29.95 |
| Forward P/E | 10.30 | 11.88 |
| EPS (TTM) | $3.80 | $0.92 |
| Dividend yield | 3.02% | 0.00% |
| Annual dividend | $2.66 | $0.00 |
| Revenue (latest FY) | $402.07B | — |
| Revenue growth (YoY) | +7.85% | — |
| Net income (latest FY) | $1.77B | — |
| Gross margin | 44.99% | — |
| Operating margin | 1.16% | — |
| Net margin | 0.44% | — |
| 52-week high | $110.68 | $33.07 |
| 52-week low | $69.51 | $16.10 |
| Distance from 52-week high | -20.54% | -16.68% |
| Analyst consensus | strong_buy | none |
| Avg. price target upside | +31.62% | +24.94% |
| Average volume | 7.91M | 1.14M |
| Shares outstanding | 1.28B | 76.73M |
| Employees | 219,000 | 835 |
| Sector | Consumer Staples | Health Care |
| Industry | Retail-Drug Stores and Proprietary Stores | Misc Health and Biotechnology Services |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- CVS Health is about 53.2 times larger than Progyny by market value ($112.49B vs $2.11B).
- PGNY has outperformed CVS by 21.6 percentage points over the past year.
- Progyny trades at a higher earnings multiple (29.9x vs 23.1x trailing P/E).
- CVS Health offers a meaningfully higher dividend yield (3.02% vs 0.00%).
- The two companies sit in different sectors: CVS Health in Consumer Staples and Progyny in Health Care.
About CVS Health
CVS stock →CVS Health Corporation provides health solutions in the United States. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services, including medical, pharmacy, dental, and behavioral health plans; medical management capabilities; Medicare Advantage and Medicare Supplement plans; prescription drug plans (PDPs); and Medicaid health care management services.
Consumer Staples · Retail-Drug Stores and Proprietary Stores · 219,000 employees
About Progyny
PGNY stock →Progyny, Inc., a benefits management company, provides fertility, family building, and women's health benefits solutions in the United States. It offers fertility benefits solutions, such as differentiated benefits plan design that includes smart cycle treatment bundle; personalized concierge-style member support services; and a selective network of fertility specialists.
Health Care · Misc Health and Biotechnology Services · 835 employees
CVS vs PGNY FAQ
Which is bigger, CVS Health or Progyny?
CVS Health (CVS) is larger, with a market capitalization of $112.49B compared with $2.11B for Progyny (PGNY).
Which stock has performed better over the past year, CVS or PGNY?
PGNY returned +37.75% over the past 12 months, compared with +16.16% for CVS (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, CVS or PGNY?
CVS has the lower trailing P/E at 23.1, versus 29.9 for PGNY. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, CVS Health or Progyny?
CVS Health pays a dividend yielding 3.02%, while Progyny does not currently pay a regular dividend.
Are CVS Health and Progyny in the same industry?
No. CVS Health is in the Consumer Staples sector, while Progyny is in Health Care.